Wegovy is also started at a low dose of 0.25 mg
In February 2021, the researchers published the findings from their trial in The New England Journal of Medicine, showing that patients using semaglutide lost almost 15% of their body weight, on average, compared with 2.4% among patients who got the placebo
Finalmente, el juego responsable no es un obstculo, sino el marco que posibilita sesiones entretenidas y sostenibles
While large-scale randomized controlled trials (RCTs) have focused on higher-dose protocols for regulatory approval, a growing number of physicians are reporting excellent results at significantly lower doses , especially in individuals who are metabolically healthy or seeking lifestyle optimization rather than aggressive weight loss
So whether youre already taking a GLP-1, looking for an oral option, or simply researching GLP-1s, were here to help